文献速递先天性心脏病外科瓣膜外科

单右心室患者二期姑息手术中三尖瓣干预的长期结局

Long-term outcomes of tricuspid valve intervention during stage 2 palliation in patients with a single right ventricle.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-05-22

本研究利用单心室重建试验及其随访2试验数据集,评估右心室优势循环患者在二期姑息手术中接受三尖瓣干预的长期结局。结果显示,二期时因三尖瓣反流行瓣膜干预的患者死亡或心脏移植风险显著高于未干预的反流患者(HR 2.93,95%CI 2.16-3.99),瓣膜干预似乎并未减轻三尖瓣反流相关风险。

要点

  • 一期或二期存在三尖瓣反流者无移植生存更差(HR 1.61,95%CI 1.12-2.32;HR 2.3,95%CI 1.39-3.82)。
  • 二期因反流行三尖瓣干预者死亡或心脏移植风险显著高于未干预的反流患者(HR 2.93,95%CI 2.16-3.99)。
  • Fontan时存在三尖瓣反流者无论是否干预结局均较好。

核心结论

  • 单心室生理患者中三尖瓣反流相关风险似乎并未因二期姑息手术时行瓣膜干预而减轻。
  • 二期时因三尖瓣反流行瓣膜干预的患者生存显著差于存在三尖瓣反流但未行干预的患者。

研究设计与样本

  • 研究使用单心室重建试验和单心室重建随访2试验数据集进行多中心分析。
  • 采用生存分析描述瓣膜反流、干预与长期生存之间的关联。
  • 采用Cox比例风险模型估计三尖瓣干预与无移植生存的纵向关联。

主要发现

  • 一期或二期存在三尖瓣反流者无移植生存更差(HR 1.61,95%CI 1.12-2.32;HR 2.3,95%CI 1.39-3.82)。
  • 存在反流并在二期行同期瓣膜干预者死亡或心脏移植风险显著高于存在反流但未干预者(HR 2.93,95%CI 2.16-3.99)。
  • Fontan时存在三尖瓣反流者无论是否行瓣膜干预结局均较好。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In patients with single ventricle physiology and a systemic right ventricle, tricuspid valve regurgitation increases the risk of adverse outcomes, and tricuspid valve intervention at the time of staged palliation further increases that risk in the postoperative period. However, long-term outcomes of valve intervention in patients with significant regurgitation during stage 2 palliation have not been established. The purpose of this study is to evaluate the long-term outcomes after tricuspid valve intervention during stage 2 palliation in patients with right ventricular dominant circulation in a multicenter study. METHODS: The study was performed using the Single Ventricle Reconstruction Trial and Single Ventricle Reconstruction Follow-up 2 Trial datasets. Survival analysis was performed to describe the association among valve regurgitation, intervention, and long-term survival. Cox proportional hazards modeling was used to estimate the longitudinal association of tricuspid intervention and transplant-free survival. RESULTS: Patients with tricuspid regurgitation at stage 1 or 2 had worse transplant-free survival (hazard ratio, 1.61; 95% confidence interval, 1.12-2.32; hazard ratio, 2.3; 95% confidence interval 1.39-3.82). Those with regurgitation who underwent concomitant valve intervention at stage 2 were significantly more likely to die or undergo heart transplantation compared with those with regurgitation who did not (hazard ratio, 2.93; confidence interval, 2.16-3.99). Patients with tricuspid regurgitation at the time of the Fontan had favorable outcomes regardless of valve intervention. CONCLUSIONS: The risks associated with tricuspid regurgitation in patients with single ventricle physiology do not appear to be mitigated by valve intervention at the time of stage 2 palliation. Patients who underwent valve intervention for tricuspid regurgitation at stage 2 had significantly worse survival compared with patients with tricuspid regurgitation who did not.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Smerling JL, Goldstone AB, Bacha EA, et al. Long-term outcomes of tricuspid valve intervention during stage 2 palliation in patients with a single right ventricle. J Thorac Cardiovasc Surg. 2023. PMID: 37225082. doi:10.1016/j.jtcvs.2023.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。